Ongoing Clinical Trials

  • A Single-center, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Dose of AP303 Following Oral Administration, and the Effect of Food on the Pharmacokinetics of AP303 in Healthy Subjects

Completed Clinical Trials

  • A Phase 2 Study to Evaluate the Safety and Efficacy of Escalated and Fixed Doses of AP301 in Comparison With Sevelamer Carbonate to Treat Hyperphosphatemia in Chronic Kidney Disease Patients Receiving Hemodialysis